Saira Ramasastry Vir Biotechnology, Inc. (VIR) insider trading activity

Saira Ramasastry is Director of Vir Biotechnology, Inc.. Currently has a direct ownership of 22,619 shares of VIR, which is worth approximately $118,297. The most recent transaction as insider was on May 30, 2025, when has been sold 8,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.6K

54.72% 3M change

54.72% 12M change

Total Value Held $118,297

Saira Ramasastry Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 30 2025	BUY Grant, award, or other acquisition	-	8,000 Added 26.13%	22,619 Common Stock
Jun 11 2024	SELL Open market or private sale	$43,800 $10.95 p/Share	4,000 Reduced 21.48%	14,619 Common Stock
May 30 2024	BUY Grant, award, or other acquisition	-	8,000 Added 30.05%	18,619 Common Stock
Jun 01 2023	SELL Open market or private sale	$89,845 $25.67 p/Share	3,500 Reduced 24.79%	10,619 Common Stock
May 22 2023	BUY Grant, award, or other acquisition	-	6,027 Added 29.92%	14,119 Common Stock
Jul 11 2022	SELL Open market or private sale	$150,000 $30.0 p/Share	5,000 Reduced 38.19%	8,092 Common Stock
Jul 11 2022	BUY Grant, award, or other acquisition	$63,800 $12.76 p/Share	5,000 Added 27.64%	13,092 Common Stock
May 24 2022	SELL Open market or private sale	$40,184 $23.82 p/Share	1,687 Reduced 17.25%	8,092 Common Stock
May 23 2022	BUY Grant, award, or other acquisition	-	6,405 Added 39.58%	9,779 Common Stock
May 21 2021	BUY Grant, award, or other acquisition	-	3,374 Added 50.0%	3,374 Common Stock
May 19 2021	SELL Open market or private sale	$437,300 $43.73 p/Share	10,000 Reduced 100.0%	0 Common Stock
May 19 2021	BUY Exercise of conversion of derivative security	$127,600 $12.76 p/Share	10,000 Added 50.0%	10,000 Common Stock

Also insider at

SGMO

SANGAMO THERAPEUTICS, INC Healthcare

Director

AKUS

Akouos, Inc. Healthcare

Director

MIRM

Mirum Pharmaceuticals, Inc. Healthcare

DAWN

Day One Biopharmaceuticals, Inc. Healthcare